Shilpa Medicare receives US approval for Varenicline Tablets, 0.5 mg and 1 mg
Shilpa’s product has been approved as a generic version to the innovator - Chantix Tablets, 0.5 mg and 1 mg, of PF Prism C.V. (PF Prism)
Shilpa’s product has been approved as a generic version to the innovator - Chantix Tablets, 0.5 mg and 1 mg, of PF Prism C.V. (PF Prism)
Data highlight ambition to transform prevention and treatment for serious bacterial infections and develop novel preventative strategies for respiratory viral infections
This partnership encompasses dossier licensing, bulk product supply, and the licensing of ZIM Labs’ proprietary Oral Thin Film technology platform, ThinOral
Raichur site is the group’s largest API facility and part of a wider network of seven sites
Mantri will replace V. S. Mani, Executive Director & Global Chief Financial Officer of the company as he has conveyed his decision to opt for early retirement
NATCO has decided to price the product at Rs.15, 900 MRP consistent with the company’s stand before the court
Introduces revolutionary approach to workflow management to enhance operational efficiency and optimize process efficiency
Asahi Kasei Life Science covers a broad range of bioprocess products and services
Fexuprazan has the longest half-life of 9 hours among potassium-competitive acid blockers
Dr Reddy’s said scheme of amalgamation was carried with adherence to all the legal requirements including tax laws
Subscribe To Our Newsletter & Stay Updated